Synergistic activity of the c-Met and tubulin inhibitor tivantinib (ARQ197) with pemetrexed in mesothelioma cells

Leticia G. Leon
PhD, PharmD

37th EORTC-PAMM Winter Meeting
Antwerp, Belgium
10 February 2016

Pdf: Synergistic activity of the c-Met and tubulin inhibitor tivantinib